Charles Schwab’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.6M | Buy |
2,889,082
+41,457
| +1% | +$467K | 0.01% | 1377 |
|
|
2025
Q1 | $28.7M | Buy |
2,847,625
+35,123
| +1% | +$354K | 0.01% | 1428 |
|
|
2024
Q4 | $33.3M | Buy |
2,812,502
+45,090
| +2% | +$533K | 0.01% | 1404 |
|
|
2024
Q3 | $31.9M | Buy |
2,767,412
+646,627
| +30% | +$7.46M | 0.01% | 1422 |
|
|
2024
Q2 | $22.4M | Buy |
2,120,785
+8,374
| +0.4% | +$88.5K | ﹤0.01% | 1603 |
|
|
2024
Q1 | $22.3M | Buy |
2,112,411
+89,384
| +4% | +$942K | 0.01% | 1545 |
|
|
2023
Q4 | $22.7M | Buy |
2,023,027
+99,148
| +5% | +$1.11M | 0.01% | 1516 |
|
|
2023
Q3 | $22.5M | Buy |
1,923,879
+1,297,134
| +207% | +$15.2M | 0.01% | 1432 |
|
|
2023
Q2 | $6.32M | Buy |
626,745
+52,630
| +9% | +$531K | ﹤0.01% | 2133 |
|
|
2023
Q1 | $4.24M | Buy |
574,115
+13,216
| +2% | +$97.5K | ﹤0.01% | 2281 |
|
|
2022
Q4 | $4.48M | Buy |
560,899
+39,268
| +8% | +$314K | ﹤0.01% | 2266 |
|
|
2022
Q3 | $1.68M | Sell |
521,631
-191,580
| -27% | -$617K | ﹤0.01% | 2627 |
|
|
2022
Q2 | $2.9M | Sell |
713,211
-10,363
| -1% | -$42.2K | ﹤0.01% | 2432 |
|
|
2022
Q1 | $3.58M | Buy |
723,574
+32,494
| +5% | +$161K | ﹤0.01% | 2437 |
|
|
2021
Q4 | $6.97M | Buy |
+691,080
| New | +$6.97M | ﹤0.01% | 2185 |
|